Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127851531 | 12785153 | 1 | I | 20160725 | 20160916 | 20160927 | 20160927 | EXP | DE-SA-2016SA173253 | AVENTIS | 79.00 | YR | E | F | Y | 0.00000 | 20160927 | CN | DE | DE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127851531 | 12785153 | 1 | PS | TOUJEO | INSULIN GLARGINE | 1 | Unknown | U | UNK | 206538 | SOLUTION FOR INJECTION | ||||||||
127851531 | 12785153 | 2 | SS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Unknown | U | UNK | 0 | |||||||||
127851531 | 12785153 | 3 | C | SOLOSTAR | DEVICE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127851531 | 12785153 | 1 | Diabetes mellitus |
127851531 | 12785153 | 2 | Diabetes mellitus |
127851531 | 12785153 | 3 | Diabetes mellitus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127851531 | 12785153 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127851531 | 12785153 | Blood glucose abnormal | |
127851531 | 12785153 | Ketoacidosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127851531 | 12785153 | 1 | 20160720 | 0 | ||
127851531 | 12785153 | 2 | 20160720 | 0 | ||
127851531 | 12785153 | 3 | 20160720 | 0 |